Consequences of NMO-IgG binding to aquaporin-4 in neuromyelitis optica

Comment

Andrea Rossi et al. Proc Natl Acad Sci U S A. 2012.

. 2012 Jun 12;109(24):E1511; author reply E1512.

doi: 10.1073/pnas.1203463109. Epub 2012 May 15.

No abstract available

Conflict of interest statement

The authors declare no conflict of interest.

Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes.
Hinson SR, Romero MF, Popescu BF, Lucchinetti CF, Fryer JP, Wolburg H, Fallier-Becker P, Noell S, Lennon VA. Hinson SR, et al. Proc Natl Acad Sci U S A. 2012 Jan 24;109(4):1245-50. doi: 10.1073/pnas.1109980108. Epub 2011 Nov 29. Proc Natl Acad Sci U S A. 2012. PMID: 22128336 Free PMC article.

1. Hinson SR, et al. Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes. Proc Natl Acad Sci USA. 2012;109:1245–1250. - PMC - PubMed
1. Hinson SR, et al. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. J Exp Med. 2008;205:2473–2481. - PMC - PubMed
1. Ratelade J, Bennett JL, Verkman AS. Evidence against cellular internalization in vivo of NMO-IgG, aquaporin-4, and excitatory amino acid transporter 2 in neuromyelitis optica. J Biol Chem. 2011;286:45156–45164. - PMC - PubMed
1. Phuan PW, Ratelade J, Rossi A, Tradtrantip L, Verkman AS. Complement-dependent cytotoxicity in neuromyelitis optica requires aquaporin-4 assembly in orthogonal arrays. J Biol Chem. 2012;287:13829–13839. - PMC - PubMed
1. Nicchia GP, et al. Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies. Glia. 2009;57:1363–1373. - PubMed